Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Equine Viral Arteritis (EVA) - Case Confirmed
Defra has confirmed a case of EVA
Defra has today reported a confirmed case of Equine Viral Arteritis (EVA) in a stallion in West Sussex.

Breeding restrictions have been put in place on the infected stallion and investigations have begun, to establish the likely origin of the infection, as well as any mares that may have been affected as well.  The disease is being controlled in line with the industry agreed Horse Betting Levy Board (HBLB) Codes of Practice.

There are no human health implications associated with this disease.


What is EVA?

Equine Viral Arteritis (EVA) is a contagious disease caused by the equine arteritis virus (EVA). The virus occurs worldwide including mainland Europe. 

There are no human health implications associated with this disease.

Equine Viral Arteritis (EVA) is a disease which is notifiable in the UK,  by law under The Equine Viral Arteritis Order 1995 made under section 88 of the Animal Health Act 1981.
Under the Order, anyone who owns, manages, inspects or examines a horse must notify their local Animal Health office when:
    •    they suspect the disease in a stallion, either on the basis of clinical signs or following blood or semen testing;
    •     they suspect disease, either on the basis of clinical signs or following blood testing, in a stallion or mare that has been mated or artificially inseminated within the past 14 days.

Full details of the exact notification requirements are in the EVA Order 1995.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.